Delipidated retroviruses as potential autologous therapeutic vaccines - A pilot experiment

Moiz Kltabwalla; Aftab A. Ansari; Francois Vlllinger; Hassibullah Akeefe; Adam P. Conner; Ann E. Mayne; James E K Hildreth

doi:10.3181/0712-RM-349

Delipidated retroviruses as potential autologous therapeutic vaccines - A pilot experiment

Moiz Kltabwalla, Aftab A. Ansari, Francois Vlllinger, Hassibullah Akeefe, Adam P. Conner, Ann E. Mayne, James E K Hildreth

Research output: Contribution to journal › Article › peer-review

Abstract

This pilot experiment in a simian immunodeficiency virus (SIV) chronic infection model aimed at extending our previous findings that vaccination with delipidated SIV resulted in more potent and diversified antiviral responses (1). Macaques chronically infected with SIVmac239 treated with antiretroviral therapy (ART) were vaccinated with autologous delipidated virus via consecutive lymph node targeted immunizations-1,1 and 10 ig of virus spaced monthly. Results showed all animals had lasting viral load reduction approaching 1 log compared to set-point, and disease delay. Delipidation may enhance processing/ presentation of viral antigen eliciting potent antiviral control even at such late infection stage.

Original language	English (US)
Pages (from-to)	732-740
Number of pages	9
Journal	Experimental Biology and Medicine
Volume	233
Issue number	6
DOIs	https://doi.org/10.3181/0712-RM-349
State	Published - Jun 2008
Externally published	Yes

Keywords

Delipidation
SIV
Therapeutic vaccination

ASJC Scopus subject areas

Biochemistry, Genetics and Molecular Biology(all)

Access to Document

10.3181/0712-RM-349

Fingerprint Dive into the research topics of 'Delipidated retroviruses as potential autologous therapeutic vaccines - A pilot experiment'. Together they form a unique fingerprint.

Cite this

@article{a0e16d102b984ab9aadf339bb13f6907,

title = "Delipidated retroviruses as potential autologous therapeutic vaccines - A pilot experiment",

abstract = "This pilot experiment in a simian immunodeficiency virus (SIV) chronic infection model aimed at extending our previous findings that vaccination with delipidated SIV resulted in more potent and diversified antiviral responses (1). Macaques chronically infected with SIVmac239 treated with antiretroviral therapy (ART) were vaccinated with autologous delipidated virus via consecutive lymph node targeted immunizations-1,1 and 10 ig of virus spaced monthly. Results showed all animals had lasting viral load reduction approaching 1 log compared to set-point, and disease delay. Delipidation may enhance processing/ presentation of viral antigen eliciting potent antiviral control even at such late infection stage.",

keywords = "Delipidation, SIV, Therapeutic vaccination",

author = "Moiz Kltabwalla and Ansari, {Aftab A.} and Francois Vlllinger and Hassibullah Akeefe and Conner, {Adam P.} and Mayne, {Ann E.} and Hildreth, {James E K}",

year = "2008",

month = jun,

doi = "10.3181/0712-RM-349",

language = "English (US)",

volume = "233",

pages = "732--740",

journal = "Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N. Y.)",

issn = "0037-9727",

publisher = "Society for Experimental Biology and Medicine",

number = "6",

}

TY - JOUR

T1 - Delipidated retroviruses as potential autologous therapeutic vaccines - A pilot experiment

AU - Kltabwalla, Moiz

AU - Ansari, Aftab A.

AU - Vlllinger, Francois

AU - Akeefe, Hassibullah

AU - Conner, Adam P.

AU - Mayne, Ann E.

AU - Hildreth, James E K

PY - 2008/6

Y1 - 2008/6

N2 - This pilot experiment in a simian immunodeficiency virus (SIV) chronic infection model aimed at extending our previous findings that vaccination with delipidated SIV resulted in more potent and diversified antiviral responses (1). Macaques chronically infected with SIVmac239 treated with antiretroviral therapy (ART) were vaccinated with autologous delipidated virus via consecutive lymph node targeted immunizations-1,1 and 10 ig of virus spaced monthly. Results showed all animals had lasting viral load reduction approaching 1 log compared to set-point, and disease delay. Delipidation may enhance processing/ presentation of viral antigen eliciting potent antiviral control even at such late infection stage.

AB - This pilot experiment in a simian immunodeficiency virus (SIV) chronic infection model aimed at extending our previous findings that vaccination with delipidated SIV resulted in more potent and diversified antiviral responses (1). Macaques chronically infected with SIVmac239 treated with antiretroviral therapy (ART) were vaccinated with autologous delipidated virus via consecutive lymph node targeted immunizations-1,1 and 10 ig of virus spaced monthly. Results showed all animals had lasting viral load reduction approaching 1 log compared to set-point, and disease delay. Delipidation may enhance processing/ presentation of viral antigen eliciting potent antiviral control even at such late infection stage.

KW - Delipidation

KW - SIV

KW - Therapeutic vaccination

UR - http://www.scopus.com/inward/record.url?scp=46449095580&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=46449095580&partnerID=8YFLogxK

U2 - 10.3181/0712-RM-349

DO - 10.3181/0712-RM-349

M3 - Article

C2 - 18408147

AN - SCOPUS:46449095580

VL - 233

SP - 732

EP - 740

JO - Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N. Y.)

JF - Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N. Y.)

SN - 0037-9727

IS - 6

ER -